Lyn has been validated for specific increases in protein levels in human psoriatic lesions and is involved in regulating the expression of STAT3 and the NF-κB pathway to mediate a chronic inflammatory syndrome resembling human psoriasis in a mouse model by pan-genomic profiling (Marchetti et al., 2009). Here, STAT3 is linked to psoriasis.